Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Japan flag Japan · Delayed Price · Currency is JPY
5,854.00
+69.00 (1.19%)
Apr 28, 2026, 3:30 PM JST
7.41%
Market Cap 435.18B
Revenue (ttm) 165.74B
Net Income (ttm) 3.66B
Shares Out 74.34M
EPS (ttm) 49.18
PE Ratio 119.03
Forward PE 41.08
Dividend 106.00 (1.83%)
Ex-Dividend Date Jun 29, 2026
Volume 213,600
Average Volume 172,485
Open 5,820.00
Previous Close 5,785.00
Day's Range 5,786.00 - 5,858.00
52-Week Range 4,850.00 - 6,140.00
Beta 0.26
RSI 47.73
Earnings Date May 8, 2026

About Kobayashi Pharmaceutical

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sh... [Read more]

Founded 1886
Employees 3,731
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4967
Full Company Profile

Financial Performance

In 2025, Kobayashi Pharmaceutical's revenue was 165.74 billion, an increase of 0.09% compared to the previous year's 165.60 billion. Earnings were 3.66 billion, a decrease of -63.68%.

Financial Statements

News

There is no news available yet.